NCT03374852 CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer Status WITHDRAWN Phase PHASE2
NCT03317886 Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer Status UNKNOWN Phase PHASE3
NCT03316326 S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer Status UNKNOWN Phase PHASE2
NCT03267316 A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT03257150 A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer Status COMPLETED Phase NA
NCT03012282 CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer Status TERMINATED Phase NA
NCT02981342 A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma Status COMPLETED Phase PHASE2
NCT02959164 Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma Status COMPLETED Phase PHASE1
NCT02929797 Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer Status UNKNOWN Phase EARLY_PHASE1
NCT02790944 Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer Status COMPLETED Phase N/A
NCT02787187 Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended? Status COMPLETED Phase NA
NCT02757859 WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT02677038 Olaparib in Treating Patients With Stage IV Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02607826 Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors Status UNKNOWN Phase NA